WY-46824
Identifiers | |
---|---|
| |
PubChem (CID) | 10314993 |
ChemSpider | 8490458 |
ChEMBL | CHEMBL511347 |
Chemical and physical data | |
Formula | C19H29ClN2O |
Molar mass | 336.89936 g/mol |
3D model (Jmol) | Interactive image |
| |
|
WY-46824 is a norepinephrine-dopamine reuptake inhibitor that was disclosed by Paige Mahaney, et al. of Wyeth in 2008.[1] The compound actually appears in an article a year earlier in 2007 but is not the main focus of the work.[2] These are the only two citations that can be found for it on PubMed. It has been patented but presumably within the framework of it being an analog of venlafaxine.[3]
It has NET binding of 46 nM, DAT = 58 nM and SERT = 18795 nM. The racemic compound was resolved into its constituent enantiomers.
References
- ↑ Mahaney, P.; Gavrin, L.; Trybulski, E.; Stack, G.; Vu, T.; Cohn, S.; Ye, F.; Belardi, J.; Santilli, A.; Sabatucci, J.; Leiter, J.; Johnston, G. H.; Bray, J. A.; Burroughs, K. D.; Cosmi, S. A.; Leventhal, L.; Koury, E. J.; Zhang, Y.; Mugford, C. A.; Ho, D. M.; Rosenzweig-Lipson, S. J.; Platt, B.; Smith, V. A.; Deecher, D. C. (2008). "Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors". Journal of Medicinal Chemistry. 51 (13): 4038–4049. doi:10.1021/jm8002262. PMID 18557608.
- ↑ Mason, J. N.; Deecher, D. C.; Richmond, R. L.; Stack, G.; Mahaney, P. E.; Trybulski, E.; Winneker, R. C.; Blakely, R. D. (2007). "Desvenlafaxine Succinate Identifies Novel Antagonist Binding Determinants in the Human Norepinephrine Transporter". Journal of Pharmacology and Experimental Therapeutics. 323 (2): 720–729. doi:10.1124/jpet.107.125716. PMID 17673606.
- ↑ U.S. Patent 4,826,844
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.